Article in Infection and immunity, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
1 citing paper in PubMed.
Frontiers in immunology · 2026
Article
4 · The record
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
5 authors.
Connor WaldronDepartment of Molecular Medicine, University of South Florida, Tampa, Florida, USA.
Sierra GeorgeDepartment of Molecular Medicine, University of South Florida, Tampa, Florida, USA.
Christina ThompsonDepartment of Molecular Medicine, University of South Florida, Tampa, Florida, USA.
Yu Hsien LiaoDepartment of Molecular Medicine, University of South Florida, Tampa, Florida, USA.
Zhiming OuyangDepartment of Molecular Medicine, University of South Florida, Tampa, Florida, USA.ORCID 0000-0001-7427-1856
Funding
Virulence regulation by BadR in the Lyme disease spirocheteR01AI152983 · NIAID · UNIVERSITY OF SOUTH FLORIDA · PI OUYANG, ZHIMING · 2021 to 2025
$1.9M
Global virulence regulatory network in the Lyme disease pathogenR01AI181738 · NIAID · UNIVERSITY OF SOUTH FLORIDA · PI Zhiming Ouyang · 2025 to 2026
$1.0M
Analysis of the DksA regulon in the Lyme disease spirocheteR21AI159061 · NIAID · UNIVERSITY OF SOUTH FLORIDA · PI OUYANG, ZHIMING · 2021 to 2022
$411k
HHS | National Institutes of Health (NIH) AI159061, AI152983NIAID NIH HHS R01 AI152983NIAID NIH HHS R01 AI181738NIAID NIH HHS R21 AI159061
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.